FI921522L - Pyrazolopyridinfoerening och foerfarande foer dess framstaellning - Google Patents

Pyrazolopyridinfoerening och foerfarande foer dess framstaellning Download PDF

Info

Publication number: FI921522L
Authority: FI; Finland
Prior art keywords: pyrazolopyridinfoerening; foerfarande foer; och foerfarande; foer dess; dess framstaellning
Prior art date: 1991-04-10

Application number

FI921522A

Other languages

English (en)

Other versions

FI100969B (fi

FI921522A0 (fi

Inventor

Youichi Shiokawa

Atsushi Akahane

Hirohito Katayama

Takafumi Mitsunaga

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-10

Filing date

1992-04-07

Publication date

1992-10-11

1992-04-07 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1992-04-07 Publication of FI921522A0 publication Critical patent/FI921522A0/fi

1992-10-11 Publication of FI921522L publication Critical patent/FI921522L/fi

1998-03-31 Application granted granted Critical

1998-03-31 Publication of FI100969B publication Critical patent/FI100969B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Developing Agents For Electrophotography (AREA)

FI921522A 1991-04-10 1992-04-07 Menetelmä valmistaa terapeuttisesti aktiivista pyratsolo£1,5-a|pyridii niyhdistettä FI100969B (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9107513		1991-04-10
GB919107513A GB9107513D0 (en)	1991-04-10	1991-04-10	Pyrazolopyridine compound and processes for preparation thereof

Publications (3)

Publication Number	Publication Date
FI921522A0 FI921522A0 (fi)	1992-04-07
FI921522L true FI921522L (fi)	1992-10-11
FI100969B FI100969B (fi)	1998-03-31

Family

ID=10692949

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI921522A FI100969B (fi)	1991-04-10	1992-04-07	Menetelmä valmistaa terapeuttisesti aktiivista pyratsolo£1,5-a\|pyridii niyhdistettä

Country Status (23)

Country	Link
US (1)	US5234930A (fi)
EP (1)	EP0516941B1 (fi)
JP (2)	JP2546470B2 (fi)
KR (1)	KR100248700B1 (fi)
CN (2)	CN100508975C (fi)
AT (1)	ATE146473T1 (fi)
AU (1)	AU653007B2 (fi)
CA (1)	CA2065644C (fi)
DE (1)	DE69215965T2 (fi)
DK (1)	DK0516941T3 (fi)
ES (1)	ES2095976T3 (fi)
FI (1)	FI100969B (fi)
GB (1)	GB9107513D0 (fi)
GR (1)	GR3022113T3 (fi)
HU (2)	HU214871B (fi)
IE (1)	IE921086A1 (fi)
IL (1)	IL101544A (fi)
MX (1)	MX9201672A (fi)
NO (1)	NO300271B1 (fi)
RU (1)	RU2069662C1 (fi)
SG (1)	SG43917A1 (fi)
TW (1)	TW205550B (fi)
UA (1)	UA27252C2 (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5541213A (en) *	1993-06-24	1996-07-30	Eisai Co., Ltd.	Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility
WO1995018128A1 (en) *	1993-12-29	1995-07-06	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine adenosine antagonists
US6214843B1 (en) *	1996-04-25	2001-04-10	Fujitsawa Pharmaceutical Co., Ltd.	Preventives and remedies for ischemic intestinal lesion and ileus
AUPO111096A0 (en) *	1996-07-18	1996-08-08	Fujisawa Pharmaceutical Co., Ltd.	New compound
US6303624B1 (en)	1997-03-18	2001-10-16	Fujisawa Pharmaceutical Co., Ltd.	Preventives and remedies for hyperphosphatemia
SE9801526D0 (sv) *	1998-04-29	1998-04-29	Astra Ab	New compounds
CA2333947C (en) *	1998-06-01	2010-09-21	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compounds as adenosine a1 antagonist for male sterility
US20040152659A1 (en) *	1999-05-12	2004-08-05	Fujisawa Pharmaceutical Co. Ltd.	Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
PE20020506A1 (es) *	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
DE60112609T2 (de) *	2000-12-15	2006-01-19	Glaxo Group Ltd., Greenford	Pyrazolopyridine
US7163940B2 (en) *	2000-12-15	2007-01-16	Smithkline Beecham Corporation	Pyrazolopyridinyl pyrimidine therapeutic compounds
WO2002072581A2 (en) *	2001-03-08	2002-09-19	Smithkline Beecham Corporation	Pyrazolopyriadine derivatives
WO2002078701A1 (en) *	2001-03-30	2002-10-10	Smithkline Beecham Corporation	Use of pyrazolopyridines as therapeutic compounds
JP4237497B2 (ja)	2001-03-30	2009-03-11	スミスクラインビーチャムコーポレーション	ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用
JP4219171B2 (ja) *	2001-04-10	2009-02-04	スミスクラインビーチャムコーポレーション	抗ウイルス性ピラゾロピリジン化合物
JP2004527560A (ja) *	2001-04-27	2004-09-09	スミスクラインビーチャムコーポレーション	ピラゾロ［１，５−α］ピリジン誘導体
AUPR548601A0 (en) *	2001-06-06	2001-06-28	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyrazinecompound and pharmaceutical use thereof
WO2003000689A1 (en) *	2001-06-21	2003-01-03	Smithkline Beecham Corporation	Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
WO2003022845A1 (en) *	2001-09-07	2003-03-20	Smithkline Beecham Corporation	Pyrazolo-pyridines for the treatment of herpes infections
WO2003031446A1 (en) *	2001-10-05	2003-04-17	Smithkline Beecham Corporation	Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
JP2005516916A (ja) *	2001-12-11	2005-06-09	スミスクラインビーチャムコーポレーション	抗ヘルペス薬としてのピラゾロ−ピリジン誘導体
EP1546148A1 (en) *	2002-10-03	2005-06-29	SmithKline Beecham Corporation	Therapeutic compounds based on pyrazolopyridine derivatives
JP5352452B2 (ja) *	2006-06-06	2013-11-27	メディシノバ，インコーポレイテッド	置換ピラゾロ［１，５−ａ］ピリジン化合物およびその使用方法
US9572528B1 (en)	2012-08-06	2017-02-21	Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center	Monitor for SIDS research and prevention

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4925849A (en) *	1987-06-15	1990-05-15	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutically useful pyrazolopyridines
GB8901423D0 (en) *	1989-01-23	1989-03-15	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof

1991
- 1991-04-10 GB GB919107513A patent/GB9107513D0/en active Pending
1992
- 1992-04-02 TW TW081102547A patent/TW205550B/zh active
- 1992-04-02 AU AU13988/92A patent/AU653007B2/en not_active Expired
- 1992-04-03 IE IE108692A patent/IE921086A1/en not_active IP Right Cessation
- 1992-04-07 FI FI921522A patent/FI100969B/fi not_active IP Right Cessation
- 1992-04-08 ES ES92106028T patent/ES2095976T3/es not_active Expired - Lifetime
- 1992-04-08 DE DE69215965T patent/DE69215965T2/de not_active Expired - Lifetime
- 1992-04-08 AT AT92106028T patent/ATE146473T1/de active
- 1992-04-08 EP EP92106028A patent/EP0516941B1/en not_active Expired - Lifetime
- 1992-04-08 SG SG1996005302A patent/SG43917A1/en unknown
- 1992-04-08 DK DK92106028.1T patent/DK0516941T3/da active
- 1992-04-09 NO NO19921413A patent/NO300271B1/no not_active IP Right Cessation
- 1992-04-09 HU HU9201213A patent/HU214871B/hu unknown
- 1992-04-09 US US07/866,215 patent/US5234930A/en not_active Expired - Lifetime
- 1992-04-09 JP JP4088735A patent/JP2546470B2/ja not_active Expired - Lifetime
- 1992-04-09 CA CA002065644A patent/CA2065644C/en not_active Expired - Lifetime
- 1992-04-09 KR KR1019920005893A patent/KR100248700B1/ko not_active Expired - Lifetime
- 1992-04-09 CN CNB971253781A patent/CN100508975C/zh not_active Expired - Lifetime
- 1992-04-09 IL IL10154492A patent/IL101544A/en not_active IP Right Cessation
- 1992-04-09 RU SU5011507/04A patent/RU2069662C1/ru active
- 1992-04-09 CN CN92103372A patent/CN1041203C/zh not_active Expired - Lifetime
- 1992-04-10 MX MX9201672A patent/MX9201672A/es unknown
1993
- 1993-06-18 UA UA93002532A patent/UA27252C2/uk unknown
1995
- 1995-06-22 HU HU95P/P00354P patent/HU211680A9/hu unknown
- 1995-11-16 JP JP7298193A patent/JP2903040B2/ja not_active Expired - Fee Related
1996
- 1996-12-19 GR GR960403475T patent/GR3022113T3/el unknown

Also Published As

Publication number	Publication date
MX9201672A (es)	1992-10-01
DE69215965T2 (de)	1997-04-10
CN1205205A (zh)	1999-01-20
GB9107513D0 (en)	1991-05-29
IL101544A (en)	1996-06-18
KR100248700B1 (ko)	2000-08-01
JP2903040B2 (ja)	1999-06-07
HU9201213D0 (en)	1992-07-28
US5234930A (en)	1993-08-10
HU214871B (hu)	1998-07-28
EP0516941B1 (en)	1996-12-18
IE921086A1 (en)	1992-10-21
KR920019787A (ko)	1992-11-20
SG43917A1 (en)	1997-11-14
HU211680A9 (en)	1995-12-28
UA27252C2 (uk)	2000-08-15
JPH08208650A (ja)	1996-08-13
CN1041203C (zh)	1998-12-16
CA2065644A1 (en)	1992-10-11
NO921413L (no)	1992-10-12
CN1067427A (zh)	1992-12-30
FI100969B (fi)	1998-03-31
RU2069662C1 (ru)	1996-11-27
JPH05112566A (ja)	1993-05-07
AU1398892A (en)	1992-10-15
AU653007B2 (en)	1994-09-15
ATE146473T1 (de)	1997-01-15
CN100508975C (zh)	2009-07-08
TW205550B (fi)	1993-05-11
CA2065644C (en)	2002-12-03
ES2095976T3 (es)	1997-03-01
EP0516941A1 (en)	1992-12-09
NO300271B1 (no)	1997-05-05
HUT61300A (en)	1992-12-28
IL101544A0 (en)	1992-12-30
DK0516941T3 (da)	1997-01-06
JP2546470B2 (ja)	1996-10-23
DE69215965D1 (de)	1997-01-30
GR3022113T3 (en)	1997-03-31
FI921522A0 (fi)	1992-04-07
NO921413D0 (no)	1992-04-09

Publication	Publication Date	Title
FI933294L (fi)	1993-07-21	Lamellartad polymerstomme och dess framstaellningsfoerfarande
FI933471A0 (fi)	1993-08-05	Polyhydroxikarboxylsyra och foerfarande foer dess framstaellning
FI911435A7 (fi)	1992-09-26	Antennstav och foerfarande foer dess framstaellning
FI925552L (fi)	1992-12-07	Nikotin-ogenomslaepplig behaollare och dess framstaellningsfoerfarande
FI931915L (fi)	1993-04-28	Iontoforetisk laekemedelavgivningselektrod och foerfarande foer dess hydratisering
FI930778L (fi)	1993-04-22	Fibergipsskiva och foerfarande foer dess framstaellning
FI924322L (fi)	1993-08-26	Hydrohunden filamentfiberdukkomposit och foerfarande foer dess framstaellning
FI920209L (fi)	1992-07-18	Saekerhetsdokument och dess framstaellningsfoerfarande.
FI934820L (fi)	1993-10-29	Mjoelkchoklad och foerfarande foer dess framstaellning
FI932452A7 (fi)	1993-05-28	Anordning foer maskintvaettning av klaeder och dess anvaendningsfoerfarande
FI935377L (fi)	1994-01-03	Blaosbildande belaeggning och foerfarande foer dess framstaellning
FI924809A0 (fi)	1992-10-23	Dielektrisk resonatoranordning och foerfarande foer dess framstaellning
FI921333L (fi)	1992-12-22	Tvaodelad ostomianordning och dess koppling med gungande laosningskil
FI935522A7 (fi)	1993-12-09	Nitroglycerinplaoster och foerfarande foer dess framstaellning
FI923629L (fi)	1993-02-15	Kopplingsstruktur med minst en kondensator och foerfarande foer dess framstaellning
FI921522L (fi)	1992-10-11	Pyrazolopyridinfoerening och foerfarande foer dess framstaellning
FI933718L (fi)	1993-08-24	Paonytt karakteriserad oxalatoxidas och dess anvaendning
FI935610A0 (fi)	1993-12-14	Smoerjmedel foer tvaotaksmotor och dess anvaendningsfoerfarande
FI934986L (fi)	1994-05-13	Med lantan stabiliserad aluminiumoxid och dess tillverkningsmetod
FI924585L (fi)	1992-10-09	Cementsammansaettning och metoder foer dess framstaellning
FI921919L (fi)	1992-10-31	Keramiskt bindemedel och dess anvaendning
FI923450L (fi)	1993-02-02	Universalprojektil och foerfarande foer dess framstaellning
FI934806L (fi)	1993-10-29	Jaestpromotor och dess anvaendning
FI925085L (fi)	1992-11-09	Behaollare och foerfarande foer dess framstaellning
FI931148L (fi)	1993-10-11	Tvaofasig smaeltfog och foerfarande foer dess framstaellning

Legal Events

Date	Code	Title	Description
2006-03-22	PC	Transfer of assignment of patent	Owner name: ASTELLAS PHARMA INC. Free format text: ASTELLAS PHARMA INC.
2012-06-11	MA	Patent expired

Date

Code

Title

Description

2006-03-22

Transfer of assignment of patent

Owner name: ASTELLAS PHARMA INC.

Free format text: ASTELLAS PHARMA INC.

2012-06-11

Patent expired